Heart Failure Medications and Indications Flashcards
NYHA I
Structural disease but no symptoms
NYHA II
Symptomatic; slight limitation of physical activity
NYHA III
Symptomatic; marked limitation of physical activity
NYHA IV
Inability to perform any physical activity without symptoms
Beta blocker
NYHA class I-IV to reduce mortality
ACEI/ARB
For all stages of HF to reduce mortality
Aldosterone antagonist (spironolactone or eplerenone)
For NYHA class III-IV HF to reduce mortality
Hydralazine plus nitrates
NYHA class III-IV and EF <40% in black and select nonblack patients (low output syndrome, hypertension) to reduce mortality
Also for patients who cannot tolerate ACEI/ARB
Diuretics
To improve symptoms of bolume overload
Valsartan-sacubitril
Substitute for an ACEI/ARB in HFrEF (NYHA II-III) in patients who have tolerated ACEI/ARB (no symptoms of hypotension)
Digitalis
Used predominantly in patients who continue to experience symptoms despite GDMT
Ivabradine
EF <35% who are in sinus rhythm with a heart rate >70/min
ICD
EF <35% and NYHA II-III OR with EF <30% and NYHA I (after GDMT)
Cardiac resynchronization therapy
NYHA class II-IV, EF <35%, AND LBBB with QRS >150ms
Cardiac transplant/LVAD
Patients with refractory HF symptoms despite maximal medical therapy